vs
Side-by-side financial comparison of HALOZYME THERAPEUTICS, INC. (HALO) and OCEANEERING INTERNATIONAL INC (OII). Click either name above to swap in a different company.
OCEANEERING INTERNATIONAL INC is the larger business by last-quarter revenue ($692.4M vs $451.8M, roughly 1.5× HALOZYME THERAPEUTICS, INC.). OCEANEERING INTERNATIONAL INC runs the higher net margin — 5.2% vs -31.3%, a 36.6% gap on every dollar of revenue. On growth, HALOZYME THERAPEUTICS, INC. posted the faster year-over-year revenue change (51.6% vs 3.6%). HALOZYME THERAPEUTICS, INC. produced more free cash flow last quarter ($217.6M vs $-76.5M). Over the past eight quarters, HALOZYME THERAPEUTICS, INC.'s revenue compounded faster (51.9% CAGR vs 1.8%).
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
Oceaneering International, Inc. is a subsea engineering and applied technology company based in Houston, Texas, U.S. that provides engineered services and hardware to customers who operate in marine, space, and other environments.
HALO vs OII — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $451.8M | $692.4M |
| Net Profit | $-141.6M | $36.1M |
| Gross Margin | 82.6% | — |
| Operating Margin | -20.6% | — |
| Net Margin | -31.3% | 5.2% |
| Revenue YoY | 51.6% | 3.6% |
| Net Profit YoY | -203.3% | -28.3% |
| EPS (diluted) | $-1.13 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $692.4M | ||
| Q4 25 | $451.8M | $668.6M | ||
| Q3 25 | $354.3M | $742.9M | ||
| Q2 25 | $325.7M | $698.2M | ||
| Q1 25 | $264.9M | $674.5M | ||
| Q4 24 | $298.0M | $713.5M | ||
| Q3 24 | $290.1M | $679.8M | ||
| Q2 24 | $231.4M | $668.8M |
| Q1 26 | — | $36.1M | ||
| Q4 25 | $-141.6M | $177.7M | ||
| Q3 25 | $175.2M | $71.3M | ||
| Q2 25 | $165.2M | $54.4M | ||
| Q1 25 | $118.1M | $50.4M | ||
| Q4 24 | $137.0M | $56.1M | ||
| Q3 24 | $137.0M | $41.2M | ||
| Q2 24 | $93.2M | $35.0M |
| Q1 26 | — | — | ||
| Q4 25 | 82.6% | 19.8% | ||
| Q3 25 | 84.4% | 20.6% | ||
| Q2 25 | 85.8% | 21.3% | ||
| Q1 25 | 81.7% | 20.0% | ||
| Q4 24 | 85.9% | 19.9% | ||
| Q3 24 | 83.0% | 19.3% | ||
| Q2 24 | 82.9% | 18.0% |
| Q1 26 | — | — | ||
| Q4 25 | -20.6% | 9.8% | ||
| Q3 25 | 61.5% | 11.6% | ||
| Q2 25 | 62.2% | 11.3% | ||
| Q1 25 | 53.4% | 10.9% | ||
| Q4 24 | 58.9% | 10.9% | ||
| Q3 24 | 56.3% | 10.5% | ||
| Q2 24 | 50.7% | 9.0% |
| Q1 26 | — | 5.2% | ||
| Q4 25 | -31.3% | 26.6% | ||
| Q3 25 | 49.5% | 9.6% | ||
| Q2 25 | 50.7% | 7.8% | ||
| Q1 25 | 44.6% | 7.5% | ||
| Q4 24 | 46.0% | 7.9% | ||
| Q3 24 | 47.2% | 6.1% | ||
| Q2 24 | 40.3% | 5.2% |
| Q1 26 | — | $0.36 | ||
| Q4 25 | $-1.13 | $1.75 | ||
| Q3 25 | $1.43 | $0.71 | ||
| Q2 25 | $1.33 | $0.54 | ||
| Q1 25 | $0.93 | $0.49 | ||
| Q4 24 | $1.06 | $0.55 | ||
| Q3 24 | $1.05 | $0.40 | ||
| Q2 24 | $0.72 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.8M | — |
| Total DebtLower is stronger | $2.1B | $488.8M |
| Stockholders' EquityBook value | $48.8M | $1.1B |
| Total Assets | $2.5B | $2.6B |
| Debt / EquityLower = less leverage | 43.89× | 0.44× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $133.8M | $695.9M | ||
| Q3 25 | $419.7M | $7.0M | ||
| Q2 25 | $61.9M | $7.0M | ||
| Q1 25 | $176.3M | $7.0M | ||
| Q4 24 | $115.8M | $504.5M | ||
| Q3 24 | $154.3M | — | ||
| Q2 24 | $187.9M | — |
| Q1 26 | — | $488.8M | ||
| Q4 25 | $2.1B | $487.4M | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | $482.0M | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.5B | — |
| Q1 26 | — | $1.1B | ||
| Q4 25 | $48.8M | $1.1B | ||
| Q3 25 | $503.9M | $907.7M | ||
| Q2 25 | $332.7M | $842.1M | ||
| Q1 25 | $482.3M | $773.1M | ||
| Q4 24 | $363.8M | $714.3M | ||
| Q3 24 | $452.7M | $698.0M | ||
| Q2 24 | $289.4M | $651.0M |
| Q1 26 | — | $2.6B | ||
| Q4 25 | $2.5B | $2.7B | ||
| Q3 25 | $2.2B | $2.5B | ||
| Q2 25 | $2.1B | $2.3B | ||
| Q1 25 | $2.2B | $2.3B | ||
| Q4 24 | $2.1B | $2.3B | ||
| Q3 24 | $2.1B | $2.4B | ||
| Q2 24 | $2.0B | $2.3B |
| Q1 26 | — | 0.44× | ||
| Q4 25 | 43.89× | 0.46× | ||
| Q3 25 | 3.00× | — | ||
| Q2 25 | 4.54× | — | ||
| Q1 25 | 3.13× | — | ||
| Q4 24 | 4.14× | 0.67× | ||
| Q3 24 | 3.32× | — | ||
| Q2 24 | 5.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $219.0M | — |
| Free Cash FlowOCF − Capex | $217.6M | $-76.5M |
| FCF MarginFCF / Revenue | 48.2% | -11.1% |
| Capex IntensityCapex / Revenue | 0.3% | 2.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $644.6M | $238.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $219.0M | $221.1M | ||
| Q3 25 | $178.6M | $101.3M | ||
| Q2 25 | $99.7M | $77.2M | ||
| Q1 25 | $154.2M | $-80.7M | ||
| Q4 24 | $178.5M | $128.4M | ||
| Q3 24 | $115.4M | $91.9M | ||
| Q2 24 | $55.8M | $52.6M |
| Q1 26 | — | $-76.5M | ||
| Q4 25 | $217.6M | $190.7M | ||
| Q3 25 | $175.6M | $77.0M | ||
| Q2 25 | $98.1M | $46.9M | ||
| Q1 25 | $153.3M | $-106.8M | ||
| Q4 24 | $175.4M | $94.5M | ||
| Q3 24 | $113.9M | $67.0M | ||
| Q2 24 | $53.2M | $29.8M |
| Q1 26 | — | -11.1% | ||
| Q4 25 | 48.2% | 28.5% | ||
| Q3 25 | 49.6% | 10.4% | ||
| Q2 25 | 30.1% | 6.7% | ||
| Q1 25 | 57.9% | -15.8% | ||
| Q4 24 | 58.9% | 13.2% | ||
| Q3 24 | 39.3% | 9.9% | ||
| Q2 24 | 23.0% | 4.5% |
| Q1 26 | — | 2.5% | ||
| Q4 25 | 0.3% | 4.6% | ||
| Q3 25 | 0.9% | 3.3% | ||
| Q2 25 | 0.5% | 4.3% | ||
| Q1 25 | 0.4% | 3.9% | ||
| Q4 24 | 1.0% | 4.7% | ||
| Q3 24 | 0.5% | 3.7% | ||
| Q2 24 | 1.1% | 3.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.24× | ||
| Q3 25 | 1.02× | 1.42× | ||
| Q2 25 | 0.60× | 1.42× | ||
| Q1 25 | 1.31× | -1.60× | ||
| Q4 24 | 1.30× | 2.29× | ||
| Q3 24 | 0.84× | 2.23× | ||
| Q2 24 | 0.60× | 1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HALO
| Royalty | $258.0M | 57% |
| Products | $122.7M | 27% |
| Proprietary Products Sales | $59.6M | 13% |
| Device Partnered Products | $12.9M | 3% |
OII
Segment breakdown not available.
